Effect of Ganoderma tsugae on chronically carbon tetrachloride-intoxicated rats

American Journal of Chinese Medicine

Volumn 32, Issue 6, 2004, Pages 841-850

  Wu, Yueh Wern ^a   Chen, Kuan Dee ^b   Lin, Wen Chuan ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Double Crane Group   (Taiwan)

Author keywords

Carbon tetrachloride; Ganoderma; Liver fibrosis; Lucidum

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CHINESE DRUG; GANODERMA TSUGAE EXTRACT; GLOBULIN; HYDROXYPROLINE; LIVER PROTEIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; GANODERMA; GANODERMA TSUGAE; INTOXICATION; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PROTHROMBIN TIME; RAT; SPLEEN WEIGHT; WATER CONTENT;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE POISONING; DISEASE MODELS, ANIMAL; GANODERMA; HYDROXYPROLINE; LIVER; LIVER FUNCTION TESTS; MEDICINE, CHINESE TRADITIONAL; ORGAN SIZE; RATS; SPLEEN;

EID: 10944244162     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X04002454     Document Type: Article

References (19)

1. Bissell, D.M., S.L. Friedman, J.J. Maher and F.J. Roll. Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology 11: 488-498, 1990.
2. Chen, D.H., W.Y. Shiou, K.C. Wang, S.Y. Huang, Y. T. Shie, C.M. Tsai, J.F. Shie and K.D. Chen. Chemotaxonomy of triterpenoid pattern of HPLC of Ganoderma lucidium and Ganoderma tsugae. J. Chin. Chem. Soc. 46: 47-51, 1999.
3. Gill, M.A. and W.R. Kircbain. Alcoholic liver disease. In: J.T. Dipiro, R.L. Talbert, G.C. Yee, G.R. Matzke, B.G. Wells and L.M. Poser (eds.) Pharmacotherapy: A Pathophysiologic Approach. Appleton&Lange, Stamford, 1997, pp. 785-800.
4. Hanauske-Abel, H.M. Fibrosis: Representive molecular elements, a basic concept, and emerging targets for suppressive treatment. In: D. Zakim and T.D. Boyer (eds.) Hepatology: A Textbook of Liver Disease. W.B. Saunders Company, Philadelphia, 1996, pp. 465-506.
5. Hsu, H.Y. Oriental Materia Medica. Oriental Healing Arts Institute, Long Beach, USA, 1986, pp. 640-641.
6. Jong, S.C. and J.M. Birmingham. Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol. 37: 101-134, 1992.
7. Kim, K.C. and I.G. Kim. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int. J. Mol. Med. 4: 273-277, 1999.
8. Lin, J.M., C.C. Lin, H.F. Chiu, J.J. Yang and S.G. Lee. Evaluation of the anti-inflammatory and liver-protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostemma pentaphyllum in rats. Am. J. Chin. Med. 21: 59-69, 1993.
9. Lin, J.M., C.C. Lin, M.F. Chen, T. Ujiie and A. Takada. Radical scavenger and anti-hepatotoxic activity of Ganoderma formosanum, Ganoderma lucidum and Ganoderma neojaponicum. J. Ethanopharmacol. 47: 33-41, 1995.
10. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
11. Neuman, R.E. and M.A. Logan. The determination of hydroxyproline. J. Biol. Chem. 184: 299-306, 1950.
12. Nishitoba, T., H. Sato, S. Shirasu and S. Sakamura. Evidence on the strain-specific terpenoid pattern of Ganoderma lucidum. Agric. Biol. Chem. 50: 2151-2154, 1986.
13. Park, E.J., G. Ko, J. Kim and D.H. Sohn. Anti-fibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol. Pharm. Bull. 20: 417-420, 1997.
14. Patocka, J. Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine. Acta Medica 35: 123-125, 1999.
15. Podolsky, D.K. and K.J. Isselbacher. Derangements of hepatic metabolism. In: J.D. Wilson, E. Braunwald, K.J. Isselbacher, R.G. Petersdor, J.B. Martin, A.S. Fauci and R.K. Root (eds.) Harrison's Principle of Internal Medicine. McGraw-Hill, New York, 1991, pp. 1311-1317.
16. Ruward, M.J., K.E. Wilkinson, B.D. Rush, T.J. Vidmar, K.M. Peters and K.S. Henley. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 10: 801-806, 1989.
17. Sturgill, M.G. and G.H. Lambert. Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clin. Chem. 43: 1512-1526, 1997.
18. Vandenberghe, J. Hepatotoxicology: Mechanisms of liver toxicity and methodological aspects. In: R.J.M. Niesink, J. De Vries and M.A. Hollinger (eds.) Toxicology: Principle and Applications. CRC Press, New York, 1996, pp. 703-723.
19. Wasser, S.P. and A.L. Weis. Therapeutic effects of substance occurring in higher basidiomycetes mushrooms: A modern perspective. Crit. Rev. Immunol. 19: 65-96, 1999.